xtracranial internal carotid artery dissection can lead to occlusion of the artery and hence cause an ischemic stroke. It is the underlying stroke mechanism in approximately 2.5% of all strokes. It is the second leading cause of stroke in patients younger than 45 years of age. Anticoagulants or antiplatelets may prevent arterial thrombosis in extracranial internal carotid artery dissection, but these benefits may be offset by increased bleeding.
ObjectivesTo determine whether antithrombotic drugs (antiplatelet drugs, anticoagulation) are effective and safe in treatment of patients with extracranial internal carotid artery dissection (eICAD), and which is the better treatment.
Search StrategyWe searched the Cochrane Stroke Group Trials Register (last searched October 3, 2002). In addition we performed comprehensive searches of the Cochrane Central Register of Controlled Trials (